3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Wilson Disease: new trials by email Literature Review of Wilson Disease trials Research Report on Wilson Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840 Bis-Choline Tetrathiomolybdate - Wilson Disease | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 31 | 2020-12-02 | 2024-10-18 |
| Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840 ALXN1840 - Wilson Disease | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 9 | 2020-09-07 | 2024-06-24 |
| Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients ALXN1840 - Wilson Disease | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 29 | 2014-11-24 | 2021-09-29 |
Hepatolenticular Degeneration (3)
Basal Ganglia Diseases (3) · Brain Diseases (3) · Brain Diseases, Metabolic (3) · Brain Diseases, Metabolic, Inborn (3) · Central Nervous System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3) · Liver Diseases (3) · Metabolic Diseases (3) · Metabolism, Inborn Errors (3) · Metal Metabolism, Inborn Errors (3) · Movement Disorders (3) · Nervous System Diseases (3)
Alexion Pharmaceuticals, Inc. (3)
United Kingdom (3) · United States (3) · New Zealand (2) · Austria (1) · Canada (1) · Denmark (1) · Germany (1) · Poland (1) · Russia (1) · Singapore (1) · Spain (1)
Eugene S. Swenson, MD, PhD (2) · Eugene Swenson, MD, PhD (1) · Peter Ksenuk, MD (1)
2019 (1)